Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 7, 2013The International Journal of Tuberculosis and Lung DiseaseOpen Access

Cost-effectiveness of Xpert® MTB/RIF for diagnosing pulmonary tuberculosis in the United States

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHoward ChoiKMKathryn MieleTwitter (United States)DDDavid W. DowdyJohns Hopkins University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Choi et al. (2013) studied this question.

synapsesocial.com/papers/6a8996051acf8e321fbd5ed7https://doi.org/10.5588/ijtld.13.0095
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Growing Burden of Tuberculosis2003 · 2,570 citations
  2. 2Rapid Molecular Detection of Tuberculosis and Rifampin Resistance2010 · 2,338 citations
  3. 3Cost-Effectiveness Analysis of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test as Used Routinely on Smear-Positive Respiratory Specimens2003 · 44 citations
  4. 4Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection2002 · 64 citations
  5. 5Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.1996 · 354 citations